[Anti-PCSK9 in coronary artery disease: genetic progress, therapeutic approaches]

Rev Prat. 2015 Mar;65(3):326-7.
[Article in French]
No abstract available

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Coronary Artery Disease / genetics
  • Coronary Artery Disease / immunology
  • Coronary Artery Disease / therapy*
  • Genetic Therapy
  • Humans
  • Proprotein Convertase 9
  • Proprotein Convertases / antagonists & inhibitors
  • Proprotein Convertases / genetics
  • Proprotein Convertases / immunology*
  • RNA, Small Interfering / therapeutic use
  • Serine Endopeptidases / genetics
  • Serine Endopeptidases / immunology*
  • Therapies, Investigational / methods
  • Therapies, Investigational / trends

Substances

  • Antibodies, Monoclonal
  • RNA, Small Interfering
  • PCSK9 protein, human
  • Proprotein Convertase 9
  • Proprotein Convertases
  • Serine Endopeptidases